Medicinal product name Starlix
Pharmaceutical form Film-coated tablet
Strength 180 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code A10BX03 Drugs used in diabetes

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(180 mg)
PVDC/PE/PVC/Al blister    EU/1/01/174/017  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/01/174/017
Date of authorisation Apr 3, 2001
Marketing authorisation holder, country Novartis Europharm Limited, Ireland